332 related articles for article (PubMed ID: 23651102)
1. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system.
Hasan AA; Madkor H; Wageh S
Drug Deliv; 2013; 20(3-4):120-6. PubMed ID: 23651102
[TBL] [Abstract][Full Text] [Related]
2. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
Aggarwal D; Garg A; Kaur IP
J Pharm Pharmacol; 2004 Dec; 56(12):1509-17. PubMed ID: 15563757
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride.
Momoh MA; Kenechukwu FC; Attama AA
Drug Deliv; 2013; 20(3-4):102-11. PubMed ID: 23650987
[TBL] [Abstract][Full Text] [Related]
4. Effect of formulation compositions on niosomal preparations.
Chaw CS; Kim KY
Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
[TBL] [Abstract][Full Text] [Related]
5. Potential Enhancement of Metformin Hydrochloride in Lipid Vesicles Targeting Therapeutic Efficacy in Diabetic Treatment.
Ossai EC; Madueke AC; Amadi BE; Ogugofor MO; Momoh AM; Okpala COR; Anosike CA; Njoku OU
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799652
[TBL] [Abstract][Full Text] [Related]
6. Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants.
Waddad AY; Abbad S; Yu F; Munyendo WL; Wang J; Lv H; Zhou J
Int J Pharm; 2013 Nov; 456(2):446-58. PubMed ID: 23998955
[TBL] [Abstract][Full Text] [Related]
7. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin.
El-Ridy MS; Abdelbary A; Essam T; El-Salam RM; Kassem AA
Drug Dev Ind Pharm; 2011 Dec; 37(12):1491-508. PubMed ID: 21707323
[TBL] [Abstract][Full Text] [Related]
8. Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes.
Kamble B; Talreja S; Gupta A; Patil D; Pathak D; Moothedath I; Duraiswamy B
Nanomedicine (Lond); 2013 Aug; 8(8):1295-305. PubMed ID: 23259778
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of metformin hydrochloride loaded-Eudragit®RSPO and Eudragit®RSPO/PLGA nanoparticles.
Cetin M; Atila A; Sahin S; Vural I
Pharm Dev Technol; 2013; 18(3):570-6. PubMed ID: 21864098
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
12. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod loaded niosomes attenuates sevoflurane induced cognitive impairments.
Weng H; Liu X; Ren Y; Li Y; Li X
Biomed Microdevices; 2021 Dec; 24(1):5. PubMed ID: 34878605
[TBL] [Abstract][Full Text] [Related]
14. Metformin hydrochloride and wound healing: from nanoformulation to pharmacological evaluation.
El-Ridy MS; Yehia SA; Elsayed I; Younis MM; Abdel-Rahman RF; El-Gamil MA
J Liposome Res; 2019 Dec; 29(4):343-356. PubMed ID: 30526146
[TBL] [Abstract][Full Text] [Related]
15. Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus.
Maestrelli F; Mura P; González-Rodríguez ML; Cózar-Bernal MJ; Rabasco AM; Di Cesare Mannelli L; Ghelardini C
Int J Pharm; 2017 Sep; 530(1-2):430-439. PubMed ID: 28778628
[TBL] [Abstract][Full Text] [Related]
16. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
Hasan AA
Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration.
Ammar HO; Haider M; Ibrahim M; El Hoffy NM
Drug Deliv; 2017 Nov; 24(1):414-421. PubMed ID: 28165822
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of niosome encapsulated insulin.
Khaksa G; D'Souza R; Lewis S; Udupa N
Indian J Exp Biol; 2000 Sep; 38(9):901-5. PubMed ID: 12561948
[TBL] [Abstract][Full Text] [Related]
19. Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium.
Jain SK; Jain RK; Chourasia MK; Jain AK; Chalasani KB; Soni V; Jain A
AAPS PharmSciTech; 2005 Sep; 6(1):E35-41. PubMed ID: 16353961
[TBL] [Abstract][Full Text] [Related]
20. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
